Clinical Trial Update: Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients. [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial assessing the safety and systemic exposure of BL-7010 in well-controlled patients with celiac disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• BL-7010 (BL-7010)

Snippet

Sponsor: BioLineRx, Ltd. | Conditions: Celiac Disease | Phase 1, Phase 2 | Status: COMPLETED